Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticians. Lixoft brings breakthrough advances to the modeling & simulation community in user-friendly tools. Lixoft products are also designed to break the preclinical/clinical/vigilance divides for modelling and simulation, and allow all stages of drug development to share informations and synthesize them in common studies.
Reproducible research and knowledge sharing require the use of common tools, libraries and languages by the academia, industry and regulation agencies. The Lixoft products are also designed for academic research scientists and students, as well as regulation agencies, and provide a perfect support for courses in PKPD and model-based drug development. Lixoft strongly encourages the use of its products for teaching purposes. Please contact us so we can help.
Lixoft maintains a close research partnership with Inria. This collaboration guarantees the most effective organization for rapid technology transfer from academic research to industry-grade software.
Lixoft was founded in 2011, after a seven years research program in statistics and modeling for drug development and clinical trials, led by Inria in collaboration with Inserm and sponsored by Johnson & Johnson, Sanofi, Novartis, Roche, Astrazeneca and Exprimo.
Lixoft is self-funded and constantly growing. Its R&D team includes software developers, statisticians, mathematicians and pharmacologists.